Replies to post #120235 on Biotech Values

[DewDiligence]

I believe they were 45% of the overall market when they were 70% of retail?

Generic Lovenox had a 44% share of dollar sales in 1Q11 (#msg-62519040).

Now you are saying they are 85% of retail in April?

That’s what IMS is reporting (#msg-63248831).

Wasn't retail 30% and GPO 70% of the total market?

Retail is approximately 30% of the US Lovenox market by prescription volume and approximately 40% by dollar sales (#msg-54355727).